PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
0.666
-0.007 (-1.04%)
Mar 9, 2026, 1:33 PM EDT - Market open
PDS Biotechnology Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 13.08 | 13.76 | 15.28 | 12.24 | 10.18 | 6.98 | |
| Research & Development | 19.15 | 22.57 | 27.76 | 29.43 | 11.25 | 7.92 | |
| Operating Expenses | 32.23 | 36.32 | 43.05 | 41.67 | 21.44 | 14.9 | |
| Operating Income | -32.23 | -36.32 | -43.05 | -41.67 | -21.44 | -14.9 | |
| Interest Expense | -5.32 | -4.67 | -4.21 | -1.32 | - | - | |
| Interest & Investment Income | 1.5 | 2.51 | 2.9 | 0.94 | 0 | 0.06 | |
| EBT Excluding Unusual Items | -36.05 | -38.48 | -44.35 | -42.05 | -21.43 | -14.85 | |
| Pretax Income | -36.05 | -38.48 | -44.35 | -42.05 | -21.43 | -14.85 | |
| Income Tax Expense | -1.17 | -0.87 | -1.41 | -1.2 | -4.52 | - | |
| Net Income | -34.88 | -37.61 | -42.94 | -40.85 | -16.92 | -14.85 | |
| Net Income to Common | -34.88 | -37.61 | -42.94 | -40.85 | -16.92 | -14.85 | |
| Shares Outstanding (Basic) | 43 | 36 | 31 | 29 | 26 | 17 | |
| Shares Outstanding (Diluted) | 43 | 36 | 31 | 29 | 26 | 17 | |
| Shares Change (YoY) | 22.46% | 17.77% | 8.23% | 11.73% | 52.86% | 243.98% | |
| EPS (Basic) | -0.81 | -1.03 | -1.39 | -1.43 | -0.66 | -0.89 | |
| EPS (Diluted) | -0.81 | -1.03 | -1.39 | -1.43 | -0.66 | -0.89 | |
| Free Cash Flow | -32.28 | -35.06 | -33.64 | -25.71 | -12.49 | -13.15 | |
| Free Cash Flow Per Share | -0.75 | -0.96 | -1.09 | -0.90 | -0.49 | -0.79 | |
| EBITDA | -32.17 | -36.26 | -42.99 | -41.62 | -21.43 | -14.89 | |
| D&A For EBITDA | 0.06 | 0.06 | 0.06 | 0.05 | 0.01 | 0.02 | |
| EBIT | -32.23 | -36.32 | -43.05 | -41.67 | -21.44 | -14.9 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.